Search research articles
Contact Us
Filters
Showing results (1-10 of 57) with videos related to
Page
of 6
Sort By:
Clinical and Experimental Rheumatology
|
January 29, 2011
Clinical relevance of switching to a second tumour necrosis factor-alpha inhibitor after discontinuation of a first tumour necrosis factor-alpha inhibitor in rheumatoid arthritis: a systematic literature review and meta-analysis
Anouck Rémy, Jerome Avouac, Laure Gossec, et al.
Disease Markers
|
May 29, 2018
Soluble CD163 as a Potential Biomarker in Systemic Sclerosis
Camelia Frantz, Sonia Pezet, Jerome Avouac, et al.
Frontiers in Immunology
|
October 31, 2018
Regulatory T Cells in Systemic Sclerosis
Camelia Frantz, Cedric Auffray, Jerome Avouac, et al.
Seminars in Arthritis and Rheumatism
|
July 5, 2011
Spleen calcifications in connective tissue disorders
Josep A Farras, Jerome Avouac, Marine Meunier, et al.
The Journal of Rheumatology
|
September 10, 2009
Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents
Eugenie Koumakis, Julien Wipff, Jerome Avouac, et al.
The Journal of Rheumatology
|
September 17, 2010
High DNA oxidative damage in systemic sclerosis
Jerome Avouac, Didier Borderie, Ovanesse Garabed Ekindjian, et al.
Clinical and Experimental Rheumatology
|
February 24, 2017
Patient phenotypes in fibromyalgia comorbid with systemic sclerosis or rheumatoid arthritis: influence of diagnostic and screening tests. Screening with the FiRST questionnaire, diagnosis with the ACR 1990 and revised ACR 2010 criteria
Serge Perrot, Mariana Peixoto, Philippe Dieudé, et al.
RMD Open
|
February 8, 2023
Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease
Omar Al Tabaa, Roba Ghossan, Alice Combier, et al.
Journal of Clinical Medicine
|
April 18, 2019
How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?-MTX in the Treat-to-Target Strategy
Peter C Taylor, Alejandro Balsa Criado, Anne-Barbara Mongey, et al.
Arthritis Research & Therapy
|
November 14, 2023
Retraction Note: Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis
Nadira Ruzehaji, Jerome Avouac, Muriel Elhai, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 57) with videos related to
Sort By:
Page
of 6
Clinical and Experimental Rheumatology
|
January 29, 2011
Clinical relevance of switching to a second tumour necrosis factor-alpha inhibitor after discontinuation of a first tumour necrosis factor-alpha inhibitor in rheumatoid arthritis: a systematic literature review and meta-analysis
Anouck Rémy, Jerome Avouac, Laure Gossec, et al.
Disease Markers
|
May 29, 2018
Soluble CD163 as a Potential Biomarker in Systemic Sclerosis
Camelia Frantz, Sonia Pezet, Jerome Avouac, et al.
Frontiers in Immunology
|
October 31, 2018
Regulatory T Cells in Systemic Sclerosis
Camelia Frantz, Cedric Auffray, Jerome Avouac, et al.
Seminars in Arthritis and Rheumatism
|
July 5, 2011
Spleen calcifications in connective tissue disorders
Josep A Farras, Jerome Avouac, Marine Meunier, et al.
The Journal of Rheumatology
|
September 10, 2009
Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents
Eugenie Koumakis, Julien Wipff, Jerome Avouac, et al.
The Journal of Rheumatology
|
September 17, 2010
High DNA oxidative damage in systemic sclerosis
Jerome Avouac, Didier Borderie, Ovanesse Garabed Ekindjian, et al.
Clinical and Experimental Rheumatology
|
February 24, 2017
Patient phenotypes in fibromyalgia comorbid with systemic sclerosis or rheumatoid arthritis: influence of diagnostic and screening tests. Screening with the FiRST questionnaire, diagnosis with the ACR 1990 and revised ACR 2010 criteria
Serge Perrot, Mariana Peixoto, Philippe Dieudé, et al.
RMD Open
|
February 8, 2023
Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease
Omar Al Tabaa, Roba Ghossan, Alice Combier, et al.
Journal of Clinical Medicine
|
April 18, 2019
How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?-MTX in the Treat-to-Target Strategy
Peter C Taylor, Alejandro Balsa Criado, Anne-Barbara Mongey, et al.
Arthritis Research & Therapy
|
November 14, 2023
Retraction Note: Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis
Nadira Ruzehaji, Jerome Avouac, Muriel Elhai, et al.
Page
of 6